BioRestorative Therapies, Inc. (NASDAQ:BRTX) Short Interest Down 28.9% in December

BioRestorative Therapies, Inc. (NASDAQ:BRTX) was the target of a significant drop in short interest during the month of December. As of December 31st, there was short interest totalling 109,000 shares, a drop of 28.9% from the December 15th total of 153,400 shares. Based on an average trading volume of 52,400 shares, the days-to-cover ratio is presently 2.1 days. Approximately 2.2% of the shares of the stock are sold short.

BioRestorative Therapies Price Performance

BRTX traded down $0.02 during trading on Wednesday, hitting $1.80. 99,399 shares of the stock traded hands, compared to its average volume of 55,222. The business has a 50 day moving average price of $1.53 and a 200 day moving average price of $1.60. BioRestorative Therapies has a twelve month low of $1.03 and a twelve month high of $3.67. The company has a market cap of $12.46 million, a price-to-earnings ratio of -1.18 and a beta of 63.13.

BioRestorative Therapies (NASDAQ:BRTX) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.35) by $0.22. The business had revenue of $0.23 million during the quarter, compared to analysts’ expectations of $0.30 million. BioRestorative Therapies had a negative net margin of 2,697.08% and a negative return on equity of 98.49%. On average, equities research analysts predict that BioRestorative Therapies will post -1.43 earnings per share for the current year.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.